Etra v. Matta

Decision Date29 March 1984
Parties, 463 N.E.2d 3 Blanche ETRA et al., as Executors of Harry Etra, Deceased, Plaintiffs, v. Raymond MATTA et al., Defendants. Raymond MATTA, Third-Party Plaintiff-Appellant, v. Bernard LOWN, Third-Party Defendant-Respondent.
CourtNew York Court of Appeals Court of Appeals

Frederick N. Gaffney and Ann R. Goodwin, New York City, for third-party plaintiff-appellant.

Steven J. Ahmuty, Jr., New York City, for third-party defendant-respondent.

OPINION OF THE COURT

PER CURIAM.

Plaintiffs have attempted, in this action, to acquire jurisdiction over a Massachusetts physician whose care of decedent was the alleged cause of death.

Plaintiffs' decedent suffered from a heart condition for which he sought treatment from a Massachusetts physician, Dr. Bernard Lown. During the course of the patient's care, which included a period of hospitalization in a Boston hospital, Dr. Lown prescribed Aprindine, an experimental drug manufactured by defendant Eli Lilly & Co. Following decedent's discharge, he returned to New York, where he came under the care and treatment of a New York physician, Dr. Raymond Matta, to whom Dr. Lown had referred him. Because decedent's treatment program involved the continued use of Aprindine, available only from a clinical investigator such as Dr. Lown, decedent was provided with a supply of the drug to take back to New York.

After decedent came under Dr. Matta's care, Dr. Lown continued to act as a consultant with respect to the drug regimen. He communicated with Dr. Matta several times by telephone and letter and spoke to decedent's wife on the telephone. It is also alleged that he sent an additional supply of Aprindine to decedent in New York. During this period, decedent returned to Boston once for further consultation with Dr. Lown. Thereafter, decedent was admitted to a New York hospital with a condition known as agranulocytosis (depressed white cell count). The treatment with Aprindine was discontinued, and decedent died within a short time.

Asserting that decedent's death was caused by a side effect of the experimental drug, plaintiffs brought this action against both the drug manufacturer and Dr. Matta. Dr. Matta then sought to implead Dr. Lown, the theory of liability resting upon Dr. Lown's failure to inform Dr. Matta of the precise side effects of the drug. Dr. Lown moved to dismiss the third-party complaint on the ground that his contacts with New York were insufficient to require him to defend a medical malpractice action here. We agree with the Appellate Division, 94 A.D.2d 581, 464 N.Y.S.2d 1001, that there is no basis for the exercise of personal jurisdiction over Dr. Lown.

It is urged that jurisdiction might properly be found under either prong of CPLR 302 (subd. [a], par. 1), which provides for the exercise of personal jurisdiction over any nondomiciliary who "transacts any business within the state or contracts anywhere to supply goods or services in the state", where the cause of action arises from those acts. It is contended that because information about Aprindine and decedent's treatment were unavailable to Dr. Matta except through Dr. Lown, Dr. Lown's treatment of his patient continued even after the patient returned to New York. The record does not, however, support the conclusion that Dr. Lown continued to act in the...

To continue reading

Request your trial
33 cases
  • Williams v. Gould, Inc.
    • United States
    • Nebraska Supreme Court
    • July 21, 1989
    ...South Dakota resident, who later moved to Idaho, although the physician forwarded the prescription to Idaho); Etra v. Matta, 61 N.Y.2d 455, 463 N.E.2d 3, 474 N.Y.S.2d 687 (1984) (New York court did not have personal jurisdiction over a Massachusetts physician who treated a New York patient ......
  • Robert M. Schneider, M.D., P.C. v. Licciardi, 19-0120
    • United States
    • New York Supreme Court
    • July 17, 2019
    ...circumstances create an equitable obligation running from the defendant to the plaintiff").Defendant cited Etra v. Matta , 61 N.Y.2d 455, 474 N.Y.S.2d 687, 463 N.E.2d 3 (1984) for the proposition that a medical provider providing consultation from another state is insufficient to invoke per......
  • Paterno v. Institution
    • United States
    • New York Supreme Court — Appellate Division
    • October 16, 2013
    ...omitted; emphasis added] ). Similar conclusions have been reached in other medical malpractice cases ( see Etra v. Matta, 61 N.Y.2d 455, 456, 474 N.Y.S.2d 687, 463 N.E.2d 3 [New York resident was first treated by Massachusetts doctor and thereafter by a New York doctor; however, the Massach......
  • Bank Brussels Lambert v. Fiddler Gonzalez & Rodriguez
    • United States
    • U.S. Court of Appeals — Second Circuit
    • March 26, 1999
    ...See, e.g., Holness v. Maritime Overseas Corp., 251 A.D.2d 220, 676 N.Y.S.2d 540, 544 (1st Dep't 1998); Etra v. Matta, 61 N.Y.2d 455, 458-59, 474 N.Y.S.2d 687, 463 N.E.2d 3 (1984). BBL argues for jurisdiction under both (i) Transaction of Business Within the State It is well settled that in ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT